Literature DB >> 30942178

Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein.

Andrew X Zhu1, Richard S Finn2, Peter R Galle3, Josep M Llovet4, Masatoshi Kudo5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30942178     DOI： 10.1016/S1470-2045(19)30165-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  21 in total

Review 1.  Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response.

Authors:  Amir A Borhani; Roberta Catania; Yuri S Velichko; Stefanie Hectors; Bachir Taouli; Sara Lewis
Journal:  Abdom Radiol (NY)       Date:  2021-04-23

2.  Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Authors:  Atsushi Hiraoka; Takashi Kumada; Shinya Fukunishi; Masanori Atsukawa; Masashi Hirooka; Kunihiko Tsuji; Toru Ishikawa; Koichi Takaguchi; Kazuya Kariyama; Ei Itobayashi; Kazuto Tajiri; Noritomo Shimada; Hiroshi Shibata; Hironori Ochi; Toshifumi Tada; Hidenori Toyoda; Keisuke Yokohama; Kazuhiro Nouso; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Korenobu Hayama; Taeang Arai; Michitaka Imai; Kouji Joko; Yohei Koizumi; Yoichi Hiasa; Kojiro Michitaka; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2019-10-18       Impact factor: 11.740

3.  Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Authors:  Atsushi Hiraoka; Takashi Kumada; Kazuya Kariyama; Hidenori Toyoda; Satoshi Yasuda; Kunihiko Tsuji; Takeshi Hatanaka; Satoru Kakizaki; Atsushi Naganuma; Toru Ishikawa; Toshifumi Tada; Koichi Takaguchi; Ei Itobayashi; Noritomo Shimada; Hiroshi Shibata; Takaaki Tanaka; Akemi Tsutsui; Takuya Nagano; Michitaka Imai; Shinichiro Nakamura; Kazuhiro Nouso
Journal:  Oncology       Date:  2021-11-29       Impact factor: 2.935

4.  A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases.

Authors:  Noriyuki Akutsu; Yujiro Kawakami; Yasunao Numata; Takehiro Hirano; Kohei Wagatsuma; Keisuke Ishigami; Shigeru Sasaki; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2022-07-14

Review 5.  Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.

Authors:  Philip Johnson; Qing Zhou; Doan Y Dao; Y M Dennis Lo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-08       Impact factor: 73.082

6.  Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.

Authors:  Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Satoshi Yasuda; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Noritomo Shimada; Kazuhito Kawata; Takaaki Tanaka; Hideko Ohama; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Michitaka Imai; Atsushi Naganuma; Yohei Koizumi; Shinichiro Nakamura; Kouji Joko; Hiroko Iijima; Yoichi Hiasa
Journal:  Cancer Med       Date:  2022-04-19       Impact factor: 4.711

7.  What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Authors:  Atsushi Hiraoka; Takashi Kumada; Toshifumi Tada; Kazuya Kariyama; Joji Tani; Shinya Fukunishi; Masanori Atsukawa; Masashi Hirooka; Kunihiko Tsuji; Toru Ishikawa; Koichi Takaguchi; Ei Itobayashi; Kazuto Tajiri; Noritomo Shimada; Hiroshi Shibata; Hironori Ochi; Kazuhito Kawata; Satoshi Yasuda; Hidenori Toyoda; Hideko Ohama; Kazuhiro Nouso; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Korenobu Hayama; Taeang Arai; Michitaka Imai; Yohei Koizumi; Shinichiro Nakamura; Kouji Joko; Kojiro Michitaka; Yoichi Hiasa; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2021-02-25       Impact factor: 11.740

Review 8.  Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life.

Authors:  Daneng Li; Sabrina Sedano; Rebecca Allen; Jun Gong; May Cho; Sunil Sharma
Journal:  Cancers (Basel)       Date:  2019-06-18       Impact factor: 6.639

Review 9.  Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine.

Authors:  Jingxian Duan; Yuling Wu; Jikui Liu; Jiajia Zhang; Zhichao Fu; Tieshan Feng; Ming Liu; Jie Han; Zhicheng Li; Shifu Chen
Journal:  J Hepatocell Carcinoma       Date:  2019-10-18

Review 10.  Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.

Authors:  Neil Mehta; Neehar Parikh; R Katie Kelley; Bilal Hameed; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-08       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.